Much information is accumulating on the effect of cerium oxide nanoparticles (CNPs) as cell-
protective agents, reducing oxidative stress through their unique ability of scavenging …

With the development of many nanomedicines designed for tumor therapy, the diverse
abilities of cerium oxide nanoparticles (CONPs) have encouraged researchers to pursue …

Cerium-based nanoparticles (CeNPs), particularly cerium oxide (CeO2), have been studied
extensively for their antioxidant and prooxidant properties. However, their complete redox …

The diverse abilities of cerium oxide nanoparticles (CONPs) have encouraged researchers
to pursue CONPs as a therapeutic agent to treat a number of diseases, including cancer. In …

Given that basal levels of reactive oxygen species (ROS) are higher in cancer cells, there is
a growing school of thought that endorses pro-oxidants as potential chemotherapeutic …

Cerium oxide nanoparticles (CNPs) are potent radical scavengers protecting cells from
oxidative insults, including ionizing radiation. Here we show that CNPs prevent X-ray …

Nanotechnology is becoming an important field of biomedical and clinical research and the
application of nanoparticles in disease may offer promising advances in treatment of many …

Recently, it has been published that cerium (Ce) oxide nanoparticles (CNP; nanoceria) are
able to downregulate tumor invasion in cancer cell lines. Redox-active CNP exhibit both …

Cerium oxide nanoparticles (CeO2-NPs) have prolifically attracted immense interest of
researchers due to their prominent anti-oxidant nature. However, these characteristics are …

Data on medical applications of cerium oxide nanoparticles CeO 2 (CONP) are promising,
yet information regarding their action in cells is incomplete and there are conflicting reports …